COCP
Cocrystal Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.13
+0.00%Margins
Gross margin
205.8%
EBITDA margin
-2876.7%
EBIT margin
-3063.6%
Net margin
-3011.5%
FCF margin
-2470.7%
-951.9%
Return on equity
-213.8%
Return on assets
-423.9%
Return on invested capital
0.05x
Asset turnover
-$8.1M
Cash from operations
$0.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026